Search

Collapsing focal segmental glomerulosclerosis (cFSGS) is characterized by rapid progression to end-stage renal disease (ESRD). We evaluated the clinicopathological spectrum of cFSGS and compared its clinical behavior to steroid and tacrolimus (TAC)-resistant noncollapsing focal segmental glomerulosclerosis (FSGS). All patients (>14 years) diagnosed with cFSGS were enrolled in the study. Staining for differentiated podocyte markers such as WT 1, PAX and KI67 were performed in all patients. The outcome and histological features of cFSGS was compared with a prospectively followed cohort of steroid and TAC-resistant noncollapsing FSGS. The study included 22 cFSGS patients and 19 cases of steroid and TAC-resistant FSGS. Complete remission, partial remission, steroid resistance, progression to ESRD and death were observed in 13.6%, 4.5%, 27.3%, 36.4% and 18.2% patients, respectively. Patients with cFSGS had higher serum creatinine and more advanced tubulointerstitial changes compared to resistant FSGS. Twenty-six percent of therapy resistant noncollapsing FSGS progressed to ESRD after two years of stopping TAC. However, there was no difference in progression to ESRD between cFSGS and therapy-resistant noncollapsing FSGS at the end of two years. Glomerular collapse in the setting of FSGS is poorly responsive to treatment and has a high rate of progression to ESRD. The long-term prognosis of cFSGS and steroid and TAC-resistant FSGS are similar. [ABSTRACT FROM PUBLISHER]

Two male patients with end-stage renal disease (ESRD) developed a spontaneous hemorrhage of one of their native kidneys and were referred to our institution. Symptoms included sudden onset abdominal pain, hematuria and shock. Symptoms were associated with a hemoglobin decrease. Computerized tomography (CT) was done and nephrectomy undertaken in both the cases. Histologic findings confirmed bleeding and there was no abnormality other than those related to renal insufficiency (cysts and atrophy). In chronic hemodialysis (HD) patients with hematuria, if other common causes are not identified spontaneous subcapsular or renal cyst rupture should be kept in mind. Surgery is our preferred treatment because of the diagnostic dilemma of tumors and the potential mortality of massive hematomas in morbid patients. [ABSTRACT FROM AUTHOR]

Whether or not completing the hepatitis B vaccination in patients who have undergone kidney transplantation in the middle of incomplete vaccination schedule leads to development of protective antibody titres is not known. This study was designed to determine whether the strategy of completing hepatitis B virus (HBV) vaccination after transplantation is efficacious. Sixty-four end-stage renal disease (ESRD) patients were screened for hepatitis B surface antigen (HBsAg), antibodies to hepatitis B surface antigen (anti-HBs), hepatitis B e-antigen (HBeAg) and HBV DNA. HBsAg negative patients received four doses of 40 µg recombinant HBV vaccine. Schedule was continued in after transplantation period if it was incomplete before transplant. Anti-Hbs titres were evaluated at 1, 3, 6, 9 and 12 months. Past HBV infection was noted in 12 patients: 10 by serology plus viraemia and two by viraemia alone. Of the 46 patients without current or past HBV infection who had received at least two doses of the vaccine before transplant, 17 each had received two and three doses and 12 had completed the schedule. Seventeen (37%) exhibited protective titres. Patients who had completed vaccination were more likely to have protective titres than those incompletely vaccinated ( P = 0.02). Five patients responded to post-transplant vaccination. Partially vaccinated patients do not mount an adequate antibody response despite continued vaccination in the post-transplant period, whereas complete vaccination provides protection in 60%. The present study data highlights the need of administration of a full schedule of HBV vaccination before kidney transplantation. Nucleic acid-based tests can identify occult HBV infection. Patients partially vaccinated against HBV do not mount an adequate antibody response despite continued vaccination in the post-transplant period. The data presented here highlights the need for administration of a full schedule of vaccination before kidney transplantation for maximal protection against HBV infection. [ABSTRACT FROM AUTHOR]

Chronic kidney disease (CKD) is a progressive disease leading to requirement of renal replacement therapy (RRT) over a period of time. Limited availability and high cost of RRT in many countries necessitates the researchers to focus on either prevention or slowing the progression of CKD. High dose probiotics have been hypothesized to metabolize the nitrogenous waste products, thus delaying the requirement of dialysis. The purpose of this short term intervention study was to study the effect of probiotic-prebiotic therapy and diet counseling on nutrition, renal progression, and overall health of CKD patients. Thirty predialysis CKD patients (21 males, 9 females) were included in the study. The diet charts were designed according to the underlying nutritional status and blood parameters. Calorie intake was 30-40kcal/kg; proteins 0.6-0.8g/kg (with at least 50% high biological value); potassium 1.5-2gm./day; and phosphorus <1gm./day. All patients were prescribed enteric coated gelatin capsules containing lyophilized Streptococcus Thermophilus, Lactobacillus Acidophilus, and Bifidobacterium Longum, in a dose of 15 billion colony forming units along with 100mg Lactitol monohydrate as prebiotic. Each patient received two capsules three times a day with each meal. The mean age was 45 years (range 18-68). The statistical analysis was done using ‘RGui’ software version 2.13.0 and the outcomes were tested using paired t-test at 5% level of significance. The mean calorie intake increased from 1479kcal/day to 1869kcal/day (p<0.0005), with significant reduction in protein, phosphorus and potassium intake. There was significant improvement in body mass index (p=0.002) and serum albumin levels (p=0.005). All but four patients showed improvement or stabilisation of glomerular filtration rate (GFR), and the mean GFR improved from 24.72ml/min to 27.73ml/min (p=0.03). There was also significant improvement in triglyceride and LDL cholesterol levels. Twenty five patients showed improvement in five point quality of life visual analogue score, while no patient reported any significant adverse event. In conclusion, this short term study of diet counselling with probiotic supplementation showed significant improvement in various parameters of CKD necessitating a longer term study. [Copyright &y& Elsevier]